The application of a specific pharmacological treatment may be conclusive for some patients while even ineffective for others. According to a report by the US FDA, this happens in up to 75% of cases.
But a new digital approach to standard medical procedures can significantly expand the diagnostic spectrum.
By correlating and assembling data coming from distributed sources (e.g., wearables, biomolecular analysis, images, records), Futuryng Healthcare builds multiple patient’s Avatars to be virtually tested with different therapies. The resulting outcomes will provide key insights to design personalized prevention programs that increase medications effectiveness while reducing time and cost.
